Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2022-02-09 09:22 am Sale | 13G | NEKTAR THERAPEUTICS NKTR | FMR LLC | 6,759,203 3.662% | -2,706,605 (-28.59%) | View |
2022-02-04 09:29 am Sale | 13G | NEKTAR THERAPEUTICS NKTR | WELLINGTON MANAGEMENT GROUP LLP | 11,383,721 6.17% | -2,008,891 (-15.00%) | View |
2022-01-27 1:59 pm Unchanged | 13G | NEKTAR THERAPEUTICS NKTR | BlackRock Inc. BLK | 26,671,803 14.5% | 0 (Unchanged) | View |
2022-01-25 6:45 pm Purchase | 13G | NEKTAR THERAPEUTICS NKTR | BlackRock Inc. BLK | 26,671,803 14.5% | 8,293,723 (+45.13%) | View |
2022-01-10 11:49 am Purchase | 13G | NEKTAR THERAPEUTICS NKTR | VANGUARD GROUP INC | 18,511,911 10.03% | 2,239,326 (+13.76%) | View |
2021-12-10 08:52 am Sale | 13G | NEKTAR THERAPEUTICS NKTR | FMR LLC | 9,465,808 5.128% | -9,483,876 (-50.05%) | View |
2021-02-12 2:53 pm Purchase | 13G | NEKTAR THERAPEUTICS NKTR | Invesco Ltd. IVZ | 35,456,949 19.8% | 3,827,815 (+12.10%) | View |
2021-02-12 12:02 pm Sale | 13G | NEKTAR THERAPEUTICS NKTR | PRIMECAP MANAGEMENT CO | 18,440,399 10.28% | -1,639,949 (-8.17%) | View |
2021-02-10 11:28 am Purchase | 13G | NEKTAR THERAPEUTICS NKTR | VANGUARD GROUP INC | 16,272,585 9.07% | 114,974 (+0.71%) | View |
2021-02-08 10:29 am Purchase | 13G | NEKTAR THERAPEUTICS NKTR | FMR LLC | 18,949,684 10.562% | 251,281 (+1.34%) | View |
2021-02-04 11:31 am Sale | 13G | NEKTAR THERAPEUTICS NKTR | WELLINGTON MANAGEMENT GROUP LLP | 13,392,612 7.47% | -2,805,567 (-17.32%) | View |
2021-01-26 6:52 pm Sale | 13G | NEKTAR THERAPEUTICS NKTR | BlackRock Inc. BLK | 18,378,080 10.2% | -39,455 (-0.21%) | View |
2020-03-10 09:40 am Purchase | 13G | NEKTAR THERAPEUTICS NKTR | FMR LLC | 18,698,403 10.53% | 3,760,377 (+25.17%) | View |
2020-02-12 2:49 pm Purchase | 13G | NEKTAR THERAPEUTICS NKTR | PRIMECAP MANAGEMENT CO | 20,080,348 11.41% | 680,326 (+3.51%) | View |
2020-02-12 08:02 am Sale | 13G | NEKTAR THERAPEUTICS NKTR | VANGUARD GROUP INC | 16,157,611 9.18% | -2,146,920 (-11.73%) | View |
2020-02-07 4:09 pm Sale | 13G | NEKTAR THERAPEUTICS NKTR | Invesco Ltd. IVZ | 31,629,134 18% | -3,014,252 (-8.70%) | View |
2020-02-07 11:26 am Sale | 13G | NEKTAR THERAPEUTICS NKTR | FMR LLC | 14,938,026 8.491% | -2,226,291 (-12.97%) | View |
2020-02-04 12:16 pm Sale | 13G | NEKTAR THERAPEUTICS NKTR | BlackRock Inc. BLK | 18,417,535 10.5% | -308,983 (-1.65%) | View |
2020-01-27 3:56 pm Purchase | 13G | NEKTAR THERAPEUTICS NKTR | WELLINGTON MANAGEMENT GROUP LLP | 16,198,179 9.21% | 5,456,814 (+50.80%) | View |
2019-11-08 4:49 pm Purchase | 13G | NEKTAR THERAPEUTICS NKTR | BlackRock Inc. BLK | 18,726,518 10.7% | 5,747,340 (+44.28%) | View |